Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Breast Neoplasms|Breast Cancer
Interventions: DRUG: AZD8931|DRUG: anastrozole|DRUG: Placebo
Sponsor: AstraZeneca